In "What's the word in the lab? Collaborate" (R&D Scoreboard, June 27), R&D expenses listed for Immunex Corp. included a one-time $346.4 million expense related to its merger with a unit of American Cyanamid Co. Excluding that expense, R&D would be $72.5 million, R&D per employee would be $92,711, and R&D as a percent of sales would be 59%.
Before it's here, it's on the Bloomberg Terminal. LEARN MORE